Published in Clin Endocrinol (Oxf) on September 01, 1983
Pharmacodynamic effects of intravenous alcohol on hepatic and gonadal hormones: influence of age and sex. Alcohol Clin Exp Res (2011) 0.86
Decreased hypothalamic growth hormone-releasing hormone content and pituitary responsiveness in hypothyroidism. J Clin Invest (1986) 0.79
Thyroid function in children with growth hormone (GH) deficiency during the initial phase of GH replacement therapy - clinical implications. Thyroid Res (2010) 0.77
L-triiodothyronine stimulates growth by means of an autocrine factor in a cultured growth-hormone-producing cell line. J Clin Invest (1987) 0.76
Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc Natl Acad Sci U S A (1979) 4.32
Nutritional regulation of the insulin-like growth factors. Endocr Rev (1994) 3.18
Disclosure of authors' conflicts of interest: a follow-up. N Engl J Med (2000) 3.16
Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci U S A (1984) 3.13
Clinical uses of insulin-like growth factor I. Ann Intern Med (1994) 2.93
Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab (2008) 2.74
Somatomedin-C stimulates the phosphorylation of the beta-subunit of its own receptor. J Biol Chem (1983) 2.55
Monoclonal antibodies to receptors for insulin and somatomedin-C. J Biol Chem (1983) 2.53
Studies of thyrotropin physiology by means of radioimmunoassay. Recent Prog Horm Res (1967) 2.48
Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest (1977) 2.46
Evidence that somatomedin is synthesized by multiple tissues in the fetus. Dev Biol (1980) 2.11
Treatment of primary hyperparathyroidism. N Engl J Med (1999) 1.97
Increased serum prolactin after administration of synthetic thyrotropin releasing hormone (TRH) in man. J Clin Endocrinol Metab (1971) 1.96
Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology (2000) 1.93
Maternal hypothyroidism and fetal development. N Engl J Med (1999) 1.92
Hormonal control of immunoreactive somatomedin production by cultured human fibroblasts. J Clin Invest (1981) 1.92
Purification of somatomedin-C from human plasma: chemical and biological properties, partial sequence analysis, and relationship to other somatomedins. Biochemistry (1980) 1.86
Behavior change after growth hormone treatment of children with short stature. J Pediatr (1998) 1.82
Response to thyrotropin releasing hormone (TRH) in normal man. J Clin Endocrinol Metab (1972) 1.82
Inhibition of thyrotropin response to thyrotropin-releasing hormone by small quantities of thyroid hormones. J Clin Invest (1972) 1.77
Nucleotide sequence analysis of a cDNA encoding human ubiquitin reveals that ubiquitin is synthesized as a precursor. J Biol Chem (1985) 1.77
The somatomedins: a family of insulinlike hormones under growth hormone control. Recent Prog Horm Res (1974) 1.76
Hypothyroidism in workers exposed to polybrominated biphenyls. N Engl J Med (1980) 1.73
Somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II mRNAs in rat fetal and adult tissues. J Biol Chem (1986) 1.67
The effect of glucocorticoids on thyrotropin secretion. J Clin Invest (1969) 1.61
Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes (2001) 1.59
Iodothyronine metabolism in rat liver homogenates. J Clin Invest (1978) 1.56
Triiodothyronine radioimmunoassay. J Clin Invest (1972) 1.54
Evidence from monoclonal antibody studies that insulin stimulates deoxyribonucleic acid synthesis through the type I somatomedin receptor. J Clin Endocrinol Metab (1985) 1.49
Explorations of the insulinlike and growth-promoting properties of somatomedin by membrane receptor assays. Adv Metab Disord (1975) 1.49
Induction of immunoreactive somatomedin C human serum by growth hormone: dose-response relationships and effect on chromatographic profiles. J Clin Endocrinol Metab (1980) 1.48
Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocr Rev (1985) 1.47
Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults. J Clin Endocrinol Metab (1995) 1.47
Thyrotropin-releasing hormone: regional distribution in rat brain. Science (1974) 1.45
Evidence for a functional role of endogenously produced somatomedinlike peptides in the regulation of DNA synthesis in cultured human fibroblasts and porcine smooth muscle cells. J Clin Invest (1985) 1.43
Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS. J Pediatr (1993) 1.43
Synthetic thyrotropin-releasing hormone. A potent stimulator of thyrotropin secretion in man. N Engl J Med (1971) 1.40
The need for more vitamin D. N Engl J Med (1998) 1.40
Sequence analysis of somatomedin-C: confirmation of identity with insulin-like growth factor I. Endocrinology (1983) 1.40
Stimulation of statural growth by recombinant insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron type) J Pediatr (1992) 1.37
Hyperthyroidism and excessive thyrotropin secretion. N Engl J Med (1972) 1.37
Epidermal growth factor (EGF) is required only during the traverse of early G1 in PDGF stimulated density-arrested BALB/c-3T3 cells. Exp Cell Res (1983) 1.36
Academic achievement and psychological adjustment in short children. The National Cooperative Growth Study. J Dev Behav Pediatr (1994) 1.34
Thyroidal and peripheral production of thyroid hormones. Review of recent findings and their clinical implications. Ann Intern Med (1977) 1.33
Evidence from radioligand assays that somatomedin-C and insulin-like growth factor-I are similar to each other and different from other somatomedins. J Clin Endocrinol Metab (1980) 1.31
Inhibition of the mitogenic effects of plasma by a monoclonal antibody to somatomedin C. Proc Natl Acad Sci U S A (1984) 1.30
Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin-C/insulinlike growth factor I. J Clin Invest (1986) 1.27
Current age of onset of puberty. Pediatrics (2000) 1.26
Neonatal and infantile hypoglycemia due to insulin excess: new aspects of diagnosis and surgical management. Ann Surg (1977) 1.26
Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency. N Engl J Med (2000) 1.24
Inappropriate antidiuresis and carcinoma of the lung: detection of arginine vasopressin in tumor extracts by immunoassay. J Clin Endocrinol Metab (1966) 1.23
Leprechaunism: studies of the relationship among hyperinsulinism, insulin resistance, and growth retardation. J Clin Endocrinol Metab (1979) 1.23
Thyrotropin response to thyrotropin releasing hormone in normal females over forty. J Clin Endocrinol Metab (1972) 1.23
Characterization of the insulin and somatomedin-C receptors in human placental cell membranes. J Clin Endocrinol Metab (1974) 1.22
Thyrotropin-releasing hormone in specific nuclei of rat brain. Science (1974) 1.19
Reduction in extrathyroidal triiodothyronine production by propylthiouracil in man. J Clin Invest (1975) 1.19
Regulation of the pituitary-thyroid axis in man: relationship of TSH concentration to concentration of free and total thyroxine in plasma. J Clin Endocrinol Metab (1967) 1.19
Competitive binding of somatomedin to the insulin receptors of adipocytes, chondrocytes, and liver membranes. Proc Natl Acad Sci U S A (1972) 1.18
Further purification and characterization of sulfation factor and thymidine factor from acromegalic plasma. J Clin Endocrinol Metab (1971) 1.18
Antidiuretic principle in malignant tumor extracts from patients with inappropriate ADH syndrome. J Clin Endocrinol Metab (1968) 1.17
Structural similarities between human receptors for somatomedin C and insulin: analysis by affinity labeling. Biochemistry (1981) 1.17
Nutritional regulation of IGF-I and IGF binding proteins. Annu Rev Nutr (1991) 1.17
Iodothyronine metabolism in liver and kidney homogenates from hyperthyroid and hypothyroid rats. Endocrinology (1978) 1.16
Dietary components that regulate serum somatomedin-C concentrations in humans. J Clin Invest (1983) 1.16
Autocrine function for insulin-like growth factor I in human small cell lung cancer cell lines and fresh tumor cells. Cancer Res (1990) 1.15
Further evidence of a target organ defect in the syndrome of testicular feminization. J Clin Endocrinol Metab (1966) 1.14
Evaluation of acromegaly by radioimmunoassay of somatomedin-C. N Engl J Med (1979) 1.13
Serum thyrotropin and thyroxine concentrations in patients recieving lithium carbonate. J Clin Endocrinol Metab (1973) 1.12
Immunochemical studies with lysine vasopressin. Endocrinology (1966) 1.12
Regulation of insulin-like growth factor-I in starvation and injury. Nutr Rev (1999) 1.12
Growth hormone levels during sleep in normal and growth hormone deficient children. Pediatrics (1971) 1.11
Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy. J Pediatr (1993) 1.11
Hyperthyroidism in Tasmania following iodide supplementation: measurements of thyroid-stimulating autoantibodies and thyrotropin. J Clin Endocrinol Metab (1975) 1.11
Elevated serum prolactin levels after pituitary-stalk section in man. N Engl J Med (1971) 1.11
Clinical studies with recombinant-DNA-derived methionyl human growth hormone in growth hormone deficient children. Lancet (1986) 1.10
Sequential addition of platelet factor and plasma to BALB/c 3T3 fibroblast cultures stimulates somatomedin-C binding early in cell cycle. Proc Natl Acad Sci U S A (1980) 1.10
Prolactin response to thyrotropin releasing hormone in normal subjects. J Clin Endocrinol Metab (1973) 1.10
Regulation of components of the ubiquitin system by insulin-like growth factor I and growth hormone in skeletal muscle of rats made catabolic with dexamethasone. Endocrinology (1999) 1.10
Estimation of the secretion rate of thyrotropin in man. J Clin Invest (1967) 1.09
Reduction of plasma immunoreactive somatomedin C during fasting in humans. J Clin Endocrinol Metab (1981) 1.08
Attempts to augment thyrotropin secretion. Effects of methimazole, methimazole-iodide, vasopressin, and glucagon. Metabolism (1970) 1.08
Effect of tri-iodothyronine replacement on the metabolic and pituitary responses to starvation. N Engl J Med (1979) 1.08
Identification of somatomedin/insulin-like growth factor immunoreactive cells in the human fetus. Pediatr Res (1987) 1.07
Biphasic concentration dependency of stimulation of myoblast differentiation by somatomedins. Am J Physiol (1986) 1.06
Serum thyroid hormone and thyrotropin concentrations during thyroxine and triiodothyronine therapy. J Clin Endocrinol Metab (1974) 1.05
The preparation and specificity of antibody to thyrotropin releasing hormone. Endocrinology (1972) 1.04
Human growth hormone and somatomedin C suppress the spontaneous release of growth hormone in unanesthetized rats. Endocrinology (1983) 1.04